SILVERCREST ASSET MANAGEMENT GROUP LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1232395
NEW YORK, NY
Position in VRTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,304,501
+$38,047 QoQ
Shares Held
16,358
+2.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SILVERCREST ASSET MANAGEMENT GROUP LLC holds $95,938,613 across 21 Biotechnology names. VRTX ranks #4 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCEL |
Vericel Corp
|
959,207 | $30,857,689 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
15,963 | $8,356,151 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
80,991 | $7,481,948 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
16,358 | $7,304,501 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
108,413 | $6,797,495 | |
| 6 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
163,633 | $5,943,150 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
|
47,931 | $5,051,927 | |
| 8 | ZYME |
Zymeworks Inc.
|
163,649 | $4,097,770 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,304,501 | 16,358 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,266,454 | 16,028 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,641,822 | 16,959 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,547,475 | 16,953 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,167,277 | 16,846 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,986,039 | 17,348 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,482,285 | 13,938 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,449,118 | 13,759 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $5,751,399 | 13,759 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,606,537 | 13,779 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,955,990 | 14,252 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,927,443 | 14,002 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,227,924 | 13,419 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,878,026 | 13,429 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,902,420 | 13,478 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,809,237 | 13,518 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,673,413 | 14,076 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,089,772 | 14,070 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,552,157 | 14,070 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,836,934 | 14,070 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,023,502 | 14,070 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,482,706 | 14,736 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,819,476 | 14,036 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $4,074,791 | 14,036 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,339,866 | 14,036 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||